Works matching IS 13524585 AND DT 2025 AND VI 31 AND IP 6

Results: 18

The relationship between cladribine and reduced regional grey matter volume loss in people with relapsing–remitting multiple sclerosis.

Published in:

2025

By:

Maccarrone, Davide;
Prados, Ferran;
Ciccarelli, Olga

Publication type:

Editorial

Safety and tolerability of conversion to siponimod from other disease-modifying therapies in patients with advancing forms of relapsing MS: Results from the EXCHANGE study.

Published in:

Multiple Sclerosis Journal, 2025, v. 31, n. 6, p. 706, doi. 10.1177/13524585251330085

By:

Fox, Robert J;
Cohan, Stanley;
Mao-Draayer, Yang;
Weinstock-Guttman, Bianca;
Cruz, Linda-Ali;
Arnould, Sophie;
Cox, Gina Mavrikis;
Bar-Or, Amit

Publication type:

Article

Treating comorbidities in multiple sclerosis is disease modifying: Yes.

Published in:

Multiple Sclerosis Journal, 2025, v. 31, n. 6, p. 635, doi. 10.1177/13524585251338750

By:

Lorefice, Lorena;
Zivadinov, Robert

Publication type:

Article

Treating comorbidities in MS is disease modifying: No.

Published in:

Multiple Sclerosis Journal, 2025, v. 31, n. 6, p. 637, doi. 10.1177/13524585251338739

By:

Lorscheider, Johannes

Publication type:

Article

The effects of gamma-tACS on cognitive impairment in multiple sclerosis: A randomized, double-blind, sham-controlled, pilot study.

Published in:

Multiple Sclerosis Journal, 2025, v. 31, n. 6, p. 728, doi. 10.1177/13524585251333575

By:

Ferrazzano, Gina;
Maccarrone, Davide;
Guerra, Andrea;
Collura, Angelo;
Satriano, Federica;
Fratino, Mariangela;
Ievolella, Fabrizio;
Belvisi, Daniele;
Amato, Maria Pia;
Centonze, Diego;
Altieri, Marta;
Conte, Antonella;
Leodori, Giorgio

Publication type:

Article

Differential Validity in the Written, Oral, and Electronic SDMT in Multiple Sclerosis.

Published in:

Multiple Sclerosis Journal, 2025, v. 31, n. 6, p. 719, doi. 10.1177/13524585251330961

By:

Greenwald, Matthew A;
Cancel Asencio, Héctor G;
Dwyer, Jenifer;
Moss, Arshe;
Wu, Tianxia;
Cortese, Irene;
Reich, Daniel S;
Gaitán, María I

Publication type:

Article

Treating comorbidities in MS is disease modifying: Commentary.

Published in:

Multiple Sclerosis Journal, 2025, v. 31, n. 6, p. 639, doi. 10.1177/13524585251338755

By:

Palladino, Raffaele

Publication type:

Article

Incidence and prevalence of neuromyelitis optica spectrum disorder in a contemporary, multi-ethnic cohort.

Published in:

Multiple Sclerosis Journal, 2025, v. 31, n. 6, p. 642, doi. 10.1177/13524585251328554

By:

Lee, Angus;
Iordanova, Radostina T;
Smith, Jessica B;
Li, Bonnie H;
Schwarzmann, Kathryn B;
Alsalek, Samir;
Habeshian, Talar S;
Budhathoki, Sakar;
Hernandez-Lopez, Viridiana;
Torres, Fernando;
Langer-Gould, Annette M

Publication type:

Article

AI-assisted identification of disability patterns within identical EDSS grades.

Published in:

Multiple Sclerosis Journal, 2025, v. 31, n. 6, p. 677, doi. 10.1177/13524585251327300

By:

Greselin, Martina;
Lu, Po-Jui;
Mroczek, Magdalena;
Cerdá-Fuertes, Nuria;
Demirtzoglou, Anastasios;
Papadopoulou, Athina;
Kuhle, Jens;
Leppert, David;
Arnould, Sophie;
Aoun, Manar;
Kappos, Ludwig;
Granziera, Cristina;
D'Souza, Marcus

Publication type:

Article

Seizure history and cognitive dysfunction in people with multiple sclerosis.

Published in:

Multiple Sclerosis Journal, 2025, v. 31, n. 6, p. 668, doi. 10.1177/13524585251326841

By:

Freedman, David E;
Oh, Jiwon;
Meza, Cecilia;
Feinstein, Anthony

Publication type:

Article

Smoking status and vascular risk factors as predictors of disability in AQP4-NMOSD and MOGAD.

Published in:

Multiple Sclerosis Journal, 2025, v. 31, n. 6, p. 658, doi. 10.1177/13524585251325069

By:

Chan, Fiona;
Berhanu, David;
Samadzadeh, Sara;
Francis, Anna;
Asgari, Nasrin;
Paul, Friedemann;
Leite, M Isabel;
Geraldes, Ruth;
Palace, Jacqueline

Publication type:

Article

Response to the letter: Longitudinal investigation of neuroimaging changes related to memory decline in multiple sclerosis: Testing a mechanistic model.

Published in:

2025

By:

Simani, Leila;
Leavitt, Victoria M

Publication type:

Letter

Longitudinal investigation of neuroimaging changes related to memory decline in multiple sclerosis: Testing a mechanistic model.

Published in:

2025

By:

Liu, Xiaoxia;
Zhang, Chongjie

Publication type:

Letter

Climate change and multiple sclerosis: Clinical challenges and strategies.

Published in:

Multiple Sclerosis Journal, 2025, v. 31, n. 6, p. 630, doi. 10.1177/13524585251322664

By:

Balshi, Alexandra

Publication type:

Article

Treatment effects of cladribine tablets on data-driven patterns of regional grey matter atrophy in multiple sclerosis.

Published in:

Multiple Sclerosis Journal, 2025, v. 31, n. 6, p. 696, doi. 10.1177/13524585251314779

By:

Barrantes-Cepas, Mar;
Noteboom, Samantha;
Colato, Elisa;
Battaglini, Marco;
Sormani, Maria Pia;
De Stefano, Nicola;
Steenwijk, Martijn D;
Koubiyr, Ismail;
Schoonheim, Menno M

Publication type:

Article

Positive impact of cladribine tablets on reducing brain atrophy in patients with relapsing-remitting multiple sclerosis: A longitudinal study.

Published in:

Multiple Sclerosis Journal, 2025, v. 31, n. 6, p. 689, doi. 10.1177/13524585251313749

By:

Achiron, Anat;
Warszawer, Yehuda;
Nissan, Yael;
Kerpel, Ariel;
Hoffmann, Chen;
Harari, Gil;
Magalashvili, David;
Tal, Sigal

Publication type:

Article

Ocrelizumab-associated cryptogenic organizing pneumonia in multiple sclerosis: Two case reports and comprehensive literature review.

Published in:

Multiple Sclerosis Journal, 2025, v. 31, n. 6, p. 740, doi. 10.1177/13524585241295677

By:

Gans, Alessandro;
Verrengia, Elena Pinuccia;
Ricchiuti, Elisabetta;
Leva, Serena;
Brajkovic, Simona;
Colombo, Daniele;
Mazzone, Antonino;
Prelle, Alessandro

Publication type:

Article

Cryptogenic organising pneumonia in patients treated with ocrelizumab.

Published in:

Multiple Sclerosis Journal, 2025, v. 31, n. 6, p. 744, doi. 10.1177/13524585241284040

By:

Lizak, Nathaniel;
Brownlee, Wallace

Publication type:

Article